We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$99.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$80.7M
3
JNJ icon
Johnson & Johnson
JNJ
+$77.7M
4
EA
Electronic Arts
EA
+$61.9M
5
DHR icon
Danaher
DHR
+$60.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTWO icon
476
Take-Two Interactive
TTWO
$46.1B
– –
-275,382
Closed -$57.2M
UAA icon
477
Under Armour
UAA
$2.6B
– –
-426,684
Closed -$7.33M
UHS icon
478
Universal Health Services
UHS
$10.5B
– –
-287,215
Closed -$39.5M
WEX icon
479
WEX
WEX
$6.31B
– –
-30,816
Closed -$6.27M
WST icon
480
West Pharmaceutical
WST
$24.9B
– –
-33,980
Closed -$9.63M
WW
481
DELISTED
WW International
WW
– –
-60,709
Closed -$1.48M
YQ
482
17 Education & Technology Group
YQ
$23.2M
– –
-13,232
Closed -$3.39M
ACCD
483
DELISTED
Accolade Inc
ACCD
– –
-28,077
Closed -$1.22M
NARI
484
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-21,635
Closed -$1.89M
DCPH
485
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-34,797
Closed -$1.99M
CCV.U
486
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
– –
-300,000
Closed -$3.15M
SYNH
487
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-489,893
Closed -$33.4M
JNCE
488
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-940,902
Closed -$6.59M
OSH
489
DELISTED
Oak Street Health, Inc.
OSH
– –
-358,250
Closed -$21.9M
ONEM
490
DELISTED
1Life Healthcare
ONEM
– –
-426,394
Closed -$18.6M
HMCOU
491
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
– –
-1,055,321
Closed -$11.6M
MKTWW
492
DELISTED
MarketWise, Inc. Warrant
MKTWW
– –
-2,004,385
Closed -$3.43M
MOTV.U
493
DELISTED
Motive Capital Corp Units, each consisting of one Class A ordinary share, and one-third of one redee
MOTV.U
– –
-400,000
Closed -$4.22M
BOWX
494
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
– –
-805,161
Closed -$8.26M
DMYI.U
495
DELISTED
dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
DMYI.U
– –
-1,456,000
Closed -$16.6M
PACE.WS
496
DELISTED
TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary
PACE.WS
– –
-311,871
Closed -$671K
RTP.WS
497
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
– –
-211,306
Closed -$687K
RTPZ.U
498
DELISTED
Reinvent Technology Partners Z Units, each consisting of one Class A ordinary share and one-fifth o
RTPZ.U
– –
-260,000
Closed -$2.96M
VIE
499
DELISTED
Viela Bio, Inc. Common Stock
VIE
– –
-284,927
Closed -$10.2M
FSDC
500
DELISTED
FS Development Corp. Class A Common Stock
FSDC
– –
-413,332
Closed -$4.55M
17 18 19
20
21

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.